drugset
drugset / Trial / NCT00887432

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

NCT00887432 ↗

Completed 132 enrolled Roswell Park Cancer Institute National Cancer Institute (NCI) · collab
RandomizedCrossoverDouble-blindTreatment

Summary

This randomized clinical trial studies how well cholecalciferol supplement works in treating patients with localized prostate cancer undergoing observation. Cholecalciferol may help prostate cancer cells become more like normal cells, and to grow and spread more slowly.

Timeline

Start
2009-04-08
Primary completion
2020-06-08
Completion
2020-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified — Oral

Indications

prostate adenocarcinoma